Please use this identifier to cite or link to this item:
https://doi.org/10.1002/bmc.1254
DC Field | Value | |
---|---|---|
dc.title | Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study | |
dc.contributor.author | Lin, H.-S. | |
dc.contributor.author | Yue, B.-D. | |
dc.contributor.author | Ho, P.C. | |
dc.date.accessioned | 2014-10-29T01:51:00Z | |
dc.date.available | 2014-10-29T01:51:00Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Lin, H.-S., Yue, B.-D., Ho, P.C. (2009). Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomedical Chromatography 23 (12) : 1308-1315. ScholarBank@NUS Repository. https://doi.org/10.1002/bmc.1254 | |
dc.identifier.issn | 02693879 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/105805 | |
dc.description.abstract | A simple HPLC-UV method was developed and validated for the quantification of pterostilbene (3,5-dimethoxy-4′-hydroxy-trans-stilbene), a pharmacologically active phytoalexin in rat plasma. The assay was carried out by measuring the UV absorbance at 320 nm. Pterostilbene and the internal standard, 3,5,4′-trimethoxy-trans-stilbene eluted at 5.7 and 9.2 min, respectively. The calibration curve (20-2000 ng/mL) was linear (R2 > 0.997). The lower limits of detection and of quantification were 6.7 and 20 ng/mL, respectively. The intra- and inter-day precisions in terms of RSD were all lower than 6%. The analytical recovery ranged from 95.5 ± 3.7 to 103.2 ± 0.7% while the absolute recovery ranged from 101.9 ± 1.1 to 104.9 ± 4.4%. This simple HPLC method was subsequently applied in a pharmacokinetic study carried out in Sprague-Dawley rats. The terminal elimination half-life and clearance of pterostilbene were 96.6 ± 23.7 min and 37.0 ± 2.5 mL/min/kg, respectively, while its absolute oral bioavailability was 12.5 ± 4.7%. Pterostilbene appeared to have better pharmacokinetic characteristics than its natural occurring analog, resveratrol. Copyright © 2009 John Wiley & Sons, Ltd. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/bmc.1254 | |
dc.source | Scopus | |
dc.subject | Absolute bioavailability | |
dc.subject | HPLC-UV | |
dc.subject | Pharmacokinetics | |
dc.subject | Pterostilbene | |
dc.subject | Resveratrol | |
dc.type | Article | |
dc.contributor.department | PHARMACY | |
dc.description.doi | 10.1002/bmc.1254 | |
dc.description.sourcetitle | Biomedical Chromatography | |
dc.description.volume | 23 | |
dc.description.issue | 12 | |
dc.description.page | 1308-1315 | |
dc.description.coden | BICHE | |
dc.identifier.isiut | 000272071700009 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.